Issue 49, 2017, Issue in Progress

Bovine serum albumin-loaded nano-selenium/ICG nanoparticles for highly effective chemo-photothermal combination therapy

Abstract

A combination of chemotherapy and photothermal treatment has already become a promising strategy for cancer treatment. Hence, it is highly desirable to develop a safe and effective delivery system. In the present study, we have developed bovine serum albumin-loaded nano-selenium (SeNPs)/indocyanine green (ICG) nanoparticles (BSINPs) that were generated by a programmed assembly method. They could simultaneously deliver SeNPs (a chemotherapeutic agent) and ICG (a photothermal agent) to tumor regions for combined chemo-photothermal therapy. BSINPs presented good monodispersity, a suitable size, fluorescence stability, and characteristic spectral features in comparison with free ICG. Moreover, the BSINPs displayed a longer retention time in tumors and a higher temperature response under laser irradiation. In addition, the process of subcellular location in vitro and the distribution of BSINPs in vivo could be monitored. The combined therapy offered by the BSINPs with laser irradiation synergistically induced the death of U87L glioma cells, and completely inhibited U87L tumor growth in vivo compared with chemo or photothermal therapy alone. Outstandingly, no tumor recurrence or treatment-induced toxicity was observed after a single-dose of BSINPs with laser irradiation. The results indicate that the well-defined BSINPs are highly desirable for cancer treatment with chemo-photothermal therapy.

Graphical abstract: Bovine serum albumin-loaded nano-selenium/ICG nanoparticles for highly effective chemo-photothermal combination therapy

Supplementary files

Article information

Article type
Paper
Submitted
26 Feb 2017
Accepted
01 Jun 2017
First published
13 Jun 2017
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2017,7, 30717-30724

Bovine serum albumin-loaded nano-selenium/ICG nanoparticles for highly effective chemo-photothermal combination therapy

G. Deng, T. Zhu, L. Zhou, J. Zhang, S. Li, Z. Sun, J. Lai, X. Meng, W. Li, P. Zhang, Y. Wu, T. Jiang, D. Ni, W. Yan, M. Zheng, P. Gong and L. Cai, RSC Adv., 2017, 7, 30717 DOI: 10.1039/C7RA02384G

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements